AngioDynamics, Inc. (ANGO) Free cash flow 2017–2026
AngioDynamics, Inc. (ANGO) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
$508,000FY2026 · since FY2017: $52.7M → $508,000
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | $508,000 | +103.5% |
| FY2025 | -$14.6M | +52.4% |
| FY2024 | -$30.7M | -721.5% |
| FY2023 | -$3.7M | +67.5% |
| FY2022 | -$11.5M | -160.8% |
| FY2021 | $18.9M | +186.8% |
| FY2020 | -$21.8M | -163.5% |
| FY2019 | $34.3M | -11.8% |
| FY2018 | $38.9M | -26.3% |
| FY2017 | $52.7M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More ANGO financial trends
ANGO RevenueANGO Net incomeANGO Net marginANGO Gross profitANGO Gross marginANGO Operating incomeANGO Operating marginANGO Operating cash flowANGO Capital expendituresANGO Return on equityANGO Stock buybacksANGO Dividends paidANGO Total assetsANGO Total liabilitiesANGO Shareholders’ equityANGO overview →